Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Chimeric Therapeutics Ltd. announced the issuance of 624,999,999 unquoted equity securities in the form of options set to expire on December 19, 2025, with an exercise price of $0.008. This latest move could attract investor interest as it involves a substantial number of options that were part of previously disclosed transactions. Investors in the stock market might find this development noteworthy as it could influence the company’s financial dynamics.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.